GMAZX | VIHAX | GMAZX / VIHAX | |
Total Expense Ratio | 0.63 | 0.17 | 371% |
Annual Report Gross Expense Ratio | 0.75 | 0.17 | 441% |
Fund Existence | 2 years | 9 years | - |
Gain YTD | 21.319 | 19.926 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000000 | 3000 | 8,333,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 334M | 11B | 3% |
Annual Yield % from dividends | 6.47 | 4.17 | 155% |
Returns for 1 year | 15.97 | 17.65 | 90% |
Returns for 3 years | N/A | 43.31 | - |
Returns for 5 years | N/A | 64.68 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ARKF | 50.16 | 0.42 | +0.84% |
ARK Fintech Innovation ETF | |||
AGD | 11.24 | 0.04 | +0.36% |
abrdn Global Dynamic Dividend Fund | |||
NVBW | 32.33 | 0.11 | +0.33% |
AllianzIM U.S. Large Cp Buffer20 Nov ETF | |||
MFUT | 14.71 | N/A | +0.01% |
Cambria Chesapeake Pure Trend ETF | |||
JDOC | 49.49 | N/A | N/A |
JPMorgan Healthcare Leaders ETF |